DE2030003A1 - alpha (p chloro) phenoxy isobutter acid square brackets on 2 (p chloro) 'phenoxy 2 methyl square brackets on propyl ester and process for the production of the same - Google Patents
alpha (p chloro) phenoxy isobutter acid square brackets on 2 (p chloro) 'phenoxy 2 methyl square brackets on propyl ester and process for the production of the sameInfo
- Publication number
- DE2030003A1 DE2030003A1 DE19702030003 DE2030003A DE2030003A1 DE 2030003 A1 DE2030003 A1 DE 2030003A1 DE 19702030003 DE19702030003 DE 19702030003 DE 2030003 A DE2030003 A DE 2030003A DE 2030003 A1 DE2030003 A1 DE 2030003A1
- Authority
- DE
- Germany
- Prior art keywords
- chloro
- phenoxy
- square brackets
- methyl
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 7
- 239000002253 acid Substances 0.000 title claims description 4
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 title claims description 3
- 238000004519 manufacturing process Methods 0.000 title claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 title claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 title 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 title 2
- 150000001875 compounds Chemical class 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000004821 distillation Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000006227 byproduct Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 230000000879 anti-atherosclerotic effect Effects 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- -1 lithium aluminum hydride Chemical compound 0.000 description 2
- 239000012429 reaction media Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- TXCGAZHTZHNUAI-UHFFFAOYSA-N clofibric acid Chemical compound OC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 TXCGAZHTZHNUAI-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
- C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
BOEHRINGERMAMHEIMGMBH 1698^U BOEHRINGERMAMHEIMGMBH 1698 ^ U
oc-(p-Chlor)-phenoxy-i3o'buttersäure-[2 '-(p-Chlor)-phenoxy-2'-methyl]—■ propylester und Verfahren zur Herstellung derselbenoc- (p-chloro) -phenoxy-130'-butyric acid- [2 '- (p-chloro) -phenoxy-2'-methyl] - ■ propyl ester and process for making the same
Die vorliegende Erfindung betrifft a-(p-Chlor)-phenoxy-isobuttersäure-[2l-(p-Chlor)phenoxy-2l-methylpropylester, Verfahren zur Herstellung dieser Verbindung sowie seine Verwendung zur Herstellung von Arzneimitteln mit antiatherosclerotischer Wirkung. Die Struktur dieses neuen Esters wird durch die Formel I wiedergegeben.The present invention relates to a- (p-chloro) -phenoxy-isobutyric acid- [2 l - (p-chloro) phenoxy-2 l -methylpropyl ester, a process for the preparation of this compound and its use for the preparation of medicaments with antiatherosclerotic action. The structure of this new ester is represented by the formula I.
Die Verbindung zeigt bemerkenswerte pharmakologische Eigenschaften, insbesondere bewirkt sie bereits in geringen Dosen eine ungewöhnlich starke Senkung der Serum-Triglyceride. Außerdem führte ihre Anwendung im Tierversuch zu einer beachtlichen Erniedrigung des Cholesterinspiegels, ohne daß unerwünschte Nebenwirkungen auftraten. Sowohl dieThe compound shows remarkable pharmacological properties, in particular, it has an unusual effect even in small doses severe reduction in serum triglycerides. In addition, their use in animal experiments led to a considerable lowering of the cholesterol level, without undesirable side effects occurring. Both the
Senkung der Serum-Triglyceride, als auch die Erniedrigung des Cholesterinspiegele übertrifft dabei die der Ausgangsverbindungen, für die Lowering of the serum triglycerides, as well as the lowering of the cholesterol exceeds that of the starting compounds for the
teilweise eine analoge Wirkung bekannt ist, beträchtlich. Die erfindungsgemäßen Verbindungen sind deshalb wirksame Arzneimittel gegen Atherosolerose. partially an analogous effect is known, considerable. The compounds according to the invention are therefore effective medicaments against atherosolerosis.
Die Herstellung der Verbindung I kann in an sich bekannter Weise daduroh erfolgen, daß man «-(p-Chlor)-phenoxy-isobuttersäure oder ein Derivat.'der Formel IIThe preparation of the compound I can be carried out in a manner known per se take place that one «- (p-chloro) -phenoxy-isobutyric acid or a derivative.'der formula II
o-C-COXo-C-COX
CH3 (II) CH 3 (II)
in der X einen reaktiven Rest bedeutetin which X is a reactive radical
109852/1921109852/1921
mit 2-(p-Chlor)-phenoxy-2-niethyl-propanol-(l) oder einer Verbindung der Formel IIIwith 2- (p-chloro) -phenoxy-2-diethyl-propanol- (l) or a compound of formula III
?H3? H 3
0-C-CH9-YO-C-CH 9 -Y
CH5 (in) CH 5 (in)
umsetzt,in der Y einen reaktiven Rest bedeutetconverts, in which Y is a reactive radical
Als reaktive Derivate der Formel II, die zur Umsetzung mit 2-(p-Chlor)-phenoxy-2-methyl-propanol, bzw. dem entsprechenden Alkoholat geeignet sind, kommen insbesondere diejenigen Verbindungen anfrage, in denen · X Halogen, eine Azid-, Acyloxy-, oder Alkoxygruppe bedeutet.As reactive derivatives of the formula II, which are used for reaction with 2- (p-chloro) -phenoxy-2-methyl-propanol, or the corresponding alcoholate are suitable, those compounds in particular are of interest in which X denotes halogen, an azide, acyloxy, or alkoxy group.
Die freie a-(p-Chlor)-phenoxy-isobuttersäure oder ihre Salze werden vorzugsweise mit Verbindungen III, in denen Y einen reaktiven anorganischen oder organischen Säurerest darstellt, umgesetzt. Als Säurerest sind z.B. Halogenide und Sulfonsäurereste gut geeignet.The free a- (p-chloro) -phenoxy-isobutyric acid or its salts are preferably reacted with compounds III in which Y represents a reactive inorganic or organic acid radical. As an acid residue e.g. halides and sulfonic acid residues are well suited.
Die Umsetzung erfolgt vorzugsweise in inerten Lösungsmitteln, wie z.B. Benzol, Chloroform, höhersiedenden Äthern etc.; gegebenenfalls bei erhöhter Temperatur. Zur Erhöhung der Ausbeute wird dabei vorzugsweise das entstehende Nebenprodukt (Wasser,Alkohol) durch Destillation kontinuierlich aus dem Reaktionsmedium entfernt, oder falls sich eine Säure bildet, durch Zusatz einer schwachen Base gebunden. Als Basen werden vorzugsweise tertiäre Amine, wie Pyridin oder Triäbhylamin, verwendet, die auch als Reaktionsmedium benutzt werden können.The reaction is preferably carried out in inert solvents, such as benzene, chloroform, higher-boiling ethers, etc .; optionally at elevated temperature. To increase the yield, the by-product (water, alcohol) formed is preferably continuously removed from the reaction medium by distillation or, if an acid is formed, bound by adding a weak base. The bases used are preferably tertiary amines, such as pyridine or triethylamine, which can also be used as the reaction medium.
Das yerfindungsgemäße Verfahren wird anhand des nachstehenden Beispiels näher erläutert.The method according to the invention is illustrated by the following example explained in more detail.
- 5 109852/1921 - 5 109852/1921
B e i a p ie 1B e i a p ie 1
Zu einer Suspension von 21,47 S (Ojl Mol) cc-(p-Chlor)-phenoxyisobuttersäure in 50 ml abs. Chloroform gibt man 0,7 ml absolutes Dimethylformamid und 13,1 g (0,ll Mol) thionylchlorid und hält 30 Min. auf Rückflußtemperatur. Danach destilliert man Chloroform und überschüssiges Thionylchlorid ab (gegen oSnde der Destillation unter Vakuum) und nimmt den trockenen Rückstand in 30 ml absolutem Eyridin auf. Die Pyridinlösung wird nun unter Rühren in eine Lösung von 20,1 g (0,1 Mol) 2-(p-Chlor)-phenoxy-2-methyl-propanol-(l) in 30 ml absolutem Pyridin eingetropft, wobei ein Niederschlag ausfällt. Man hält während des Zutropfens auf ca. 25 C, rührt anschließend zwei Stunden bei Raumtemperatur und gießt das Reaktionsgemisch dann in kaltes V/asser. Nach Ansäuern mit verd. Salzsäure extrahiert man mit Äther, wäscht die Ätherphase nacheinander mit verd. Salzsäure, mit wäßriger Natriumcarbonatlösung und mit Wasser, trocknet (Natriumsulfat) und dampft dann den Äther ab. Durch Zugeben von etwas Methanol kristallisiert der Ester aus. Nach Umkristallisieren aus Isopropanol erhält man 27,0 g (6Q °/o ä. Th.) farblose Kristalle vom Schmp. 51-520C (Sdp. 187-188°C bei 0,15 Torr). Die Struktur des erhaltenen a-(p-Chlor)-phenoxy-isobuttersäure-[2l-(p-Chlor)-phenoxy-2-methyl]-propy !esters wird durch Spektren und Elementaranalyse bestätigt. Die Darstellung des 2-(p-Chlor)-phenoxy-2-niethyl-propanols erfolgt durch Reduktion des cx-(p-Chlor)-phenoxy-isobuttersäureäthylesters mit Lithiumaluminium-hydrid: To a suspension of 21.47 S (Ojl mole) cc (p-chloro) -phenoxyisobuttersäure in 50 m l of abs. 0.7 ml of absolute dimethylformamide and 13.1 g (0.1 mol) of thionyl chloride are added to chloroform and the mixture is kept at reflux temperature for 30 minutes. Thereafter, chloroform and excess thionyl chloride are distilled off (towards the end of the distillation under vacuum) and the dry residue is taken up in 30 ml of absolute eyridine. The pyridine solution is then added dropwise with stirring to a solution of 20.1 g (0.1 mol) of 2- (p-chloro) -phenoxy-2-methyl-propanol- (l) in 30 ml of absolute pyridine, a precipitate separating out . During the dropwise addition, the mixture is kept at about 25 ° C., then stirred for two hours at room temperature and the reaction mixture is then poured into cold water. After acidification with dilute hydrochloric acid, the mixture is extracted with ether, the ether phase is washed successively with dilute hydrochloric acid, with aqueous sodium carbonate solution and with water, dried (sodium sulfate) and the ether is then evaporated off. The ester crystallizes out by adding some methanol. After recrystallization from isopropanol g (6Q ° / o ä. Th.) To obtain 27.0 colorless crystals of mp. 51-52 0 C (bp. 187-188 ° C at 0.15 torr). The structure of the obtained α- (p-chloro) -phenoxy-isobutyric acid- [2 l - (p-chloro) -phenoxy-2-methyl] -propyester is confirmed by spectra and elemental analysis. The preparation of 2- (p-chloro) -phenoxy-2-niethyl-propanol is carried out by reducing the cx- (p-chloro) -phenoxy-isobutyric acid ethyl ester with lithium aluminum hydride:
Eine Lösung von 24,27 g (0,1 Mol) a-(p-Chlor)-phenoxy-isobuttersäureäthylesters
in 50 ml abs. Äther wird sehr langsam und unter Kühlen zu
einer Suspension von 4g Lithium-aluminium-hydrid in 200 ml abs. Äther
zugetropft. Anschließend wird 2 Std. auf Siedetemperatur gehalten, dann
durch Zugabe von gesättigter Kochsalzlösung zersetzt und filtriert. Nach
dem Abdestillieren des Äthers erhält man den rohen Alkohol in praktisch
quantitativer Ausbeute. Nach Destillation 17,4 (87 # d. Th.) farblose
Flüssigkeit vom Sdp. I45-I460 bei 13 Torr
Sdp. 109-111° bei 0,4 TorrA solution of 24.27 g (0.1 mol) of a- (p-chloro) -phenoxy-isobutyric acid ethyl ester in 50 ml of abs. Ether becomes very slowly and with cooling to a suspension of 4g lithium aluminum hydride in 200 ml abs. Ether added dropwise. The mixture is then kept at boiling temperature for 2 hours, then decomposed by adding saturated sodium chloride solution and filtered. After the ether has been distilled off, the crude alcohol is obtained in a practically quantitative yield. After distillation, 17.4 (87 # d. Th.) Of colorless liquid, bp. I45-I46 0 at 13 Torr
109-111 ° at 0.4 torr
2020th
D = X D = X
109852/1921109852/1921
Claims (5)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19702030003 DE2030003A1 (en) | 1970-06-18 | 1970-06-18 | alpha (p chloro) phenoxy isobutter acid square brackets on 2 (p chloro) 'phenoxy 2 methyl square brackets on propyl ester and process for the production of the same |
| CH872271A CH557325A (en) | 1970-06-18 | 1971-06-15 | PROCESS FOR THE PREPARATION OF (ALPHA) - (P-CHLORINE) -PHENOXY-ISOBUTTERIC ACID- (2 '- (P-CHLORO) -PHENOXY-2'-METHYL) -PROPYLESTER. |
| GB1291010D GB1291010A (en) | 1970-06-18 | 1971-06-16 | |
| FR7121792A FR2100774B1 (en) | 1970-06-18 | 1971-06-16 | |
| AT525371A AT308081B (en) | 1970-06-18 | 1971-06-17 | Process for the preparation of the new α- (p-chlorophenoxy) isobutyric acid [2 '- (p-chlorophenoxy) -2'-methyl] propyl ester |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19702030003 DE2030003A1 (en) | 1970-06-18 | 1970-06-18 | alpha (p chloro) phenoxy isobutter acid square brackets on 2 (p chloro) 'phenoxy 2 methyl square brackets on propyl ester and process for the production of the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2030003A1 true DE2030003A1 (en) | 1971-12-23 |
Family
ID=5774287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19702030003 Pending DE2030003A1 (en) | 1970-06-18 | 1970-06-18 | alpha (p chloro) phenoxy isobutter acid square brackets on 2 (p chloro) 'phenoxy 2 methyl square brackets on propyl ester and process for the production of the same |
Country Status (5)
| Country | Link |
|---|---|
| AT (1) | AT308081B (en) |
| CH (1) | CH557325A (en) |
| DE (1) | DE2030003A1 (en) |
| FR (1) | FR2100774B1 (en) |
| GB (1) | GB1291010A (en) |
-
1970
- 1970-06-18 DE DE19702030003 patent/DE2030003A1/en active Pending
-
1971
- 1971-06-15 CH CH872271A patent/CH557325A/en not_active IP Right Cessation
- 1971-06-16 GB GB1291010D patent/GB1291010A/en not_active Expired
- 1971-06-16 FR FR7121792A patent/FR2100774B1/fr not_active Expired
- 1971-06-17 AT AT525371A patent/AT308081B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2100774A1 (en) | 1972-03-24 |
| AT308081B (en) | 1973-06-25 |
| GB1291010A (en) | 1972-09-27 |
| FR2100774B1 (en) | 1975-01-17 |
| CH557325A (en) | 1974-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1518020A1 (en) | Process for the preparation of aryl-substituted alkanoic acids | |
| AT391866B (en) | METHOD FOR PRODUCING NEW S-TRIAZOLO (1,5-A) PYRIMIDINE | |
| DE2030003A1 (en) | alpha (p chloro) phenoxy isobutter acid square brackets on 2 (p chloro) 'phenoxy 2 methyl square brackets on propyl ester and process for the production of the same | |
| CH417630A (en) | Process for the preparation of new cyclic 2,3-O-acetals and 2,3-O-ketals of butanetetrol esters | |
| AT242150B (en) | Process for the preparation of new, substituted dihydroquinoxalones (2) and their salts and quaternary ammonium compounds | |
| DE2112778B2 (en) | Process for the preparation of 2-CyBn-S ^ Ae-IeITaChIOr- or bromobenzoic acid alkyl esters | |
| DE69308757T2 (en) | 1-Phenybicyclo-2,2,2-octane derivatives, process for their preparation and pharmaceutical compositions containing them | |
| AT256839B (en) | Process for the preparation of new substituted 1-Cyclopropylmethy-piperidinen | |
| CH411847A (en) | Process for the production of camphor derivatives | |
| AT282630B (en) | Process for the production of new cinnamic acid amides | |
| AT203002B (en) | Process for the preparation of new, heterocyclically substituted pyrazolone derivatives | |
| EP0175264B1 (en) | Process for the preparation of 2-amino-3-cyano-5-dialkoxymethyl pyrazines and intermediates for this process | |
| DE1643928C3 (en) | Process for the preparation of alkylaminoalkyl ethers of cycloalkanols | |
| DE925475C (en) | Process for the preparation of 1- (m-oxyphenyl) -1-oxo-2-aralkylamino-propanes | |
| AT228197B (en) | Process for the preparation of new pyrazolone derivatives | |
| AT336004B (en) | PROCESS FOR PREPARING NEW 3- (4-BIPHENYLYL) BUTTER ACIDS, THEIR ESTERS, AMIDES AND SALTS | |
| AT165072B (en) | Process for the preparation of new pyridinium compounds | |
| AT222116B (en) | Process for the preparation of new, 4-substituted 1,2-diaryl-3,5-dioxo-pyrazolidines | |
| AT275518B (en) | Process for the preparation of new 1- (4-oxo-4-phenyl-butyl) -piperidines substituted in the 4-position and of their acid addition salts | |
| AT134629B (en) | Process for the preparation of amino alcohols. | |
| DE1545687B2 (en) | 1- (5'-Oxohexyl) -3,7-dimethylxanthine and process for its preparation | |
| DE2312256C3 (en) | 5-pyrazole acetic acid derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| AT332867B (en) | PROCESS FOR THE PREPARATION OF NEW 3- (4-BIPHENYLYL) BUTTER ACIDS, THEIR ESTERS, AMIDES AND SALT | |
| AT336590B (en) | PROCESS FOR PREPARING NEW 3- (4- BIPHENYLYL) BUTTER ACIDS, THEIR ESTERS, AMIDES AND SALT | |
| DE1670626A1 (en) | Process for the preparation of new esters containing dimethyltropane skeleton |